Skip to main content

Thought control used to release drugs contained in nanobots into living host

No, it’s not a scene from a 1980s David Cronenberg horror/sci-fi movie: researchers really have managed to use human brain waves to remotely control drug-releasing nanobots inside a living cockroach.

The work was carried out by Israeli researchers and published under the title “Thought-Controlled Nanoscale Robots in a Living Host,” in a recent issue of the academic journal PLoS ONE.

Recommended Videos

“On a high level, what we achieved is putting nanorobots inside a living host, a cockroach in this particular setup,” lead author Shachar Arnon, a former computer science graduate student at the Interdisciplinary Center in Herzliya, Israel, told Digital Trends. “We were then able to activate them using our brain, and used that interface to make them release a drug, controlled entirely by our thoughts.”

The nanoscale robots were created by folding DNA, using a method devised by Dr. Ido Bachelet, who also worked on the project. These nanobots open up when heated, releasing a glowing chemical in this study. They were placed into metal coils hooked up to a generator, which produced heat, and were injected into tropical locusts — which were reportedly unharmed by the experiment.

experiment-setup-outline
Image used with permission by copyright holder

When the human subjects wore electroencephalogram (EEG) helmets to record the electrical activity from their brains, the researchers were able to use machine learning technology to work out when their brains were producing a certain amount of activity. When brain activity hit a desired threshold, the nanoscale robots then released their cargo.

According to Arnon, it’s the first “proof of concept” step of the dream of one day using thoughts to control nanorobot-directed drugs as a delivery method within a person. It may be a while, though, before this can be used for medical treatment on people.

“Using EEG technology, I think one day this is going to be something which could be very reliable for medical use — as a way of controlling drug release inside a person’s body using a nanorobot,” he said. “It makes real sense. From something that would have been considered science-fiction just a few years ago, this is now something that is potentially very practical.”

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Jaguar Land Rover, Nissan hit the brake on shipments to U.S. over tariffs
Range Rover Sport P400e

Jaguar Land Rover (JLR) has announced it will pause shipments of its UK-made cars to the United States this month, while it figures out how to respond to President Donald Trump's 25% tariff on imported cars.

"As we work to address the new trading terms with our business partners, we are taking some short-term actions, including a shipment pause in April, as we develop our mid- to longer-term plans," JLR said in a statement sent to various media.

Read more
DeepSeek readies the next AI disruption with self-improving models
DeepSeek AI chatbot running on an iPhone.

Barely a few months ago, Wall Street’s big bet on generative AI had a moment of reckoning when DeepSeek arrived on the scene. Despite its heavily censored nature, the open source DeepSeek proved that a frontier reasoning AI model doesn’t necessarily require billions of dollars and can be pulled off on modest resources.

It quickly found commercial adoption by giants such as Huawei, Oppo, and Vivo, while the likes of Microsoft, Alibaba, and Tencent quickly gave it a spot on their platforms. Now, the buzzy Chinese company’s next target is self-improving AI models that use a looping judge-reward approach to improve themselves.

Read more
Toyota shifts gears: 15 New EVs and a million cars by 2027
Front three quarter view of the 2023 Toyota bZ4X.

After years of cautiously navigating the electric vehicle (EV) market, Toyota is finally ramping up its commitment to fully electric vehicles.
The Japanese automaker, which has long relied on hybrids, is now planning to develop about 15 fully electric models by 2027, up from five currently. These models will include vehicles under the Toyota and Lexus brands, with production expected to reach 1 million units annually by that year, according to a report from Nikkei.
This strategy marks a significant shift for Toyota, which has thus far remained conservative in its approach to electric cars. The company sold just 140,000 EVs globally in 2024—representing less than 2% of its total global sales. Despite this, Toyota is aiming for a much larger presence in the EV market, targeting approximately 35% of its global production to be electric by the end of the decade.
The Nikkei report suggests the company plans to diversify its production footprint beyond Japan and China and expanding into the U.S., Thailand, and Argentina. This would help mitigate the impact of President Donald Trump’s 25% tariffs on all car imports, as well as reduce delivery times. Toyota is also building a battery plant in North Carolina.
For now, Toyota has only two fully electric vehicles on the U.S. market: The bZ4X  and the Lexus RZ models. The Japanese automaker is expected to introduce new models like the bZ5X and a potential electric version of the popular Tacoma pickup.
Separately, Toyota and Honda, along with South Korea’s Hyundai, all announced on April 4 that they would not be raising prices, at least over the next couple of months, following the imposition of U.S. tariffs. According to a separate Nikkei report, Toyota’s North American division has told its suppliers that it will absorb the extra costs of parts imported from Mexico and Canada. Another 25% for automotive parts imported to the U.S. is slated to come into effect on May 3.

Read more